NovoCure Limited Total Liabilities
NovoCure Limited (NVCR) had Total Liabilities of $457.10 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-07-23
- 2026-06-30: Liabilities $457.10M.
- 2026-03-31: Liabilities $457.21M.
- 2025-12-31: Liabilities $463.86M.
- 2025-09-30: Liabilities $1.02B.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $457.10M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $457.21M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $463.86M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $1.02B 10-Q · filed 2025-10-30 |
| 2025-06-30 | $896.43M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $886.85M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $880.61M 10-K · filed 2026-02-26 |
| 2024-09-30 | $861.21M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $850.42M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $762.07M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $783.63M 10-K · filed 2025-02-27 |
| 2023-09-30 | $752.65M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $743.33M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $742.19M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $750.48M 10-K · filed 2024-02-22 |
| 2022-09-30 | $728.81M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $721.00M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $714.33M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $729.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $707.29M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $699.79M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $695.50M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $575.46M 10-K · filed 2022-02-24 |
| 2020-09-30 | $124.01M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $261.12M 10-Q/A · filed 2020-10-02 |
| 2020-03-31 | $260.50M 10-Q/A · filed 2020-10-02 |
| 2019-12-31 | $261.66M 10-K · filed 2021-02-25 |
| 2019-09-30 | $253.49M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $247.28M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $243.86M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $227.53M 10-K · filed 2020-02-27 |
| 2018-09-30 | $200.58M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $197.79M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $197.36M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $151.73M 10-K · filed 2019-02-28 |
| 2017-09-30 | $145.59M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $139.50M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $135.73M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $139.74M 10-K · filed 2018-02-22 |
| 2016-09-30 | $132.85M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $63.87M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $58.59M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $56.52M 10-K · filed 2017-02-23 |
| 2015-09-30 | $52.56M 10-Q · filed 2015-10-27 |
| 2014-12-31 | $20.00M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |